Key facts
- It has raised $111.4M; the latest was Later Stage VC ($27.9M) in Aug 2025.
- Notable investors include Qiming Venture Partners, GL Ventures, Intel Capital, Hillhouse Investment Group, Eastern Bell Venture Capital — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Huimei Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Huimei Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Huimei Technology
Developer of an artificial intelligence-integrated healthcare management system designed to empower medical service institutions. The company's platform uses AI algorithms to automate PDCA cycles in healthcare management in order to improve patient outcomes from pre-diagnosis to post-diagnosis stages, enabling hospitals and doctors to improve the quality and efficiency of medical services for their patients.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2013
- Website
- huimei.net/
- Ownership
- Privately Held (backing)
Huimei Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Huimei Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Huimei Technology in its N-PORT filings yet. We sweep new filings monthly.